AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23809278
Drug: Levonorgestrel (LNG)
RxNorm normalized name: Levonorgestrel
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Levonorgestrel (LNG) 1.5 mg
Trial: 10987677
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone substitution (2 IU/m2) for 12 months
Trial: 7992358
Drug: Towne strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Towne strain attenuated CMV vaccine
Trial: 49737
Drug: Placebo therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo therapy (general relaxation)
Trial: 27481122
Drug: Biological outcome
RxNorm normalized name: beremagene geperpavec
DrugBank: Beremagene geperpavec (DB17831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological outcome variables
Trial: 9291200
Drug: Usual-protein diet
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual-protein diet (1.3 g/kg/day)
Trial: 9291200
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.58 g/kg/day)
Trial: 9291200
Drug: Very-low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very-low-protein diet (0.28 g/kg/day) supplemented with a ketoacid-amino acid mixture (0.28 g/kg/day)
Trial: 3543705
Drug: Oral colistin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral colistin
Trial: 3543705
Drug: Prophylactic use
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic use of antibiotics
Trial: 21122063
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination (FDC) of pioglitazone 15mg/metformin 850mg twice daily (bid)
Trial: 21122063
Drug: Metformin 850mg
RxNorm normalized name: METFORMIN 850MG/PIOGLITAZONE 15MG TAB
DrugBank: Metformin (DB00331)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Metformin 850mg bid
Trial: 15301640
Drug: Cognitive‐behavioral treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral treatment (CBT)
Trial: 9052519
Drug: 4-aminosalicylic acid
RxNorm normalized name: 4-aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 4-aminosalicylic acid (4-ASA) 6 g per day for 6 weeks
Trial: 19112513
Drug: 15 microg
RxNorm normalized name: Tafluprost 15 microgram/mL eye drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 microg HA with aluminium hydroxide adjuvant (half dose)
Trial: 19112513
Drug: 3.8 microg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.8 microg HA without adjuvant (half dose)
Trial: 10342944
Drug: Oral cefpodoxime
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cefpodoxime
Trial: 10342944
Drug: Amoxicillin +
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin + clavulanate
Trial: 11322266
Drug: Didanosine once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine once daily (270 mg/m2/day)
Trial: 11322266
Drug: Didanosine twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine twice daily (270 mg/m2/day)
Trial: 11322266
Drug: Didanosine twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Didanosine twice daily
Trial: 1556423
Drug: Oxygen (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen (2 L by nasal prongs)
Trial: 24635120
Drug: VR graded
RxNorm normalized name: Prostin VR
DrugBank: Alprostadil (DB00770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VR graded exposure therapy (VR‐GET)
Trial: 21083769
Drug: 1.8 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.8 g/day of Lippia citriodora extracts (PLX(®) -group)
Trial: 16858168
Drug: Glomerular filtration
RxNorm normalized name: SNAIL SECRETION FILTRATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glomerular filtration rate in mL/min/1.73 m(2)
Trial: 12963590
Drug: Osteopathic manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic manipulative treatment plus routine pediatric care
Trial: 10394475
Drug: Olanzapine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (25 mg/day for 8 weeks)
Trial: 10394475
Drug: Clozapine (693
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (693 mg/day for 8 weeks)
Trial: 6147549
Drug: Prednisolone only
RxNorm normalized name: Prednisolone only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone only (0.3 mg/kg daily, increased weekly)
Trial: 31449915
Drug: TLR3 agonist
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TLR3 agonist
Trial: 31449915
Drug: Cytokine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine treatment
Trial: 29553081
Drug: Commercial anesthetic
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial anesthetic gels
Trial: 24285122
Drug: CapsoCam capsule
RxNorm normalized name: Capsicum
DrugBank: Capsicum (DB10897)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CapsoCam capsule
Trial: 19412831
Drug: 114 g
RxNorm normalized name: Hydrocortisone 1.14 g in 114 g TOPICAL LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 114 g SBC
Trial: 19412831
Drug: 60 g
RxNorm normalized name: aspirin 60 Grains
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 g SBC with 144 g cooked paddy‐rice
Trial: 19412831
Drug: 144 g
RxNorm normalized name: TITANIUM DIOXIDE 0.018 g in 180 mL / HYPOCHLOROUS ACID 0.0144 g in 180 mL TOPICAL GEL [Beklyn Absolute Purifying Hand Gel Refreshing Aloe 180ml]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 144 g cooked paddy‐rice
Trial: 17618137
Drug: Tizanidine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tizanidine (4 mg in the evenings for the first 2 postoperative days)
Trial: 17618137
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (antibiotic and anti-inflammatory medications only)
Trial: 15321438
Drug: Ondansetron 4
RxNorm normalized name: ondansetron 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 4 mg (group O4, n = 23)
Trial: 15321438
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg (group O8, n = 25)
Trial: 12243809
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin, vinblastine, and mitomycin-C (later dropped) followed by surgery
Trial: 12243809
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy with cisplatin, vinblastine (without mitomycin-C) followed by radiation therapy (RT)
Trial: 12243809
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy followed by surgery or RT
Trial: 12243809
Drug: Induction chemotherapy
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction chemotherapy only
Trial: 2550402
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg MK-906
Trial: 2550402
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg MK-906
Trial: 25475413
Drug: THC/CBD oromucosal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: THC/CBD oromucosal spray
Trial: 21956711
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with pioglitazone (45 mg/day) and exenatide (10 μg twice daily) for 12 months
Trial: 19930832
Drug: BG >or=
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BG >or= 80 mg/dl
Trial: 19930832
Drug: TV <or=
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TV <or= 6 ml/kg
Trial: 19930832
Drug: Analgesia monitoring,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Analgesia monitoring, sedation monitoring, MAP >or= 60 mmHg, BG >or= 80 mg/dl and <or= 130 mg/dl, PIP <or= 35 cmH(2)O, TV <or= 6 ml/kg
Trial: 12502992
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of local anesthetic and opioid (n = 34)
Trial: 12502992
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care analgesic regimen (intramuscular meperidine, n = 34)
Trial: 10921442
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation (control group)
Trial: 8699777
Drug: Placebo (+500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (+500 mg of metamizol)
Trial: 31277102
Drug: Xiao'er Feire
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xiao'er Feire Kechuan Oral Solution
Trial: 31277102
Drug: Macrolide antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macrolide antibiotics (erythromycin and azithromycin)
Trial: 26330437
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 1000 mg plus Vitamin E 1000 IU
Trial: 23676961
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of epidural and general anesthesia (Group C)
Trial: 16606934
Drug: Glatiramer acetate
RxNorm normalized name: Glatiramer Acetate
DrugBank: Glatiramer (DB05259)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glatiramer acetate (daily or biweekly injections)
Trial: 11246616
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg orally) followed by octreotide (100 microg subcutaneously)
Trial: 11246616
Drug: Octreotide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide (100 microg subcutaneously) in patients receiving beta-blockers
Trial: 9101010
Drug: Metformin with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin with insulin
Trial: 8287573
Drug: Oestrogen replacement
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen replacement therapy (oestradiol valerate 2 mg/day)
Trial: 3449561
Drug: Oral solution
RxNorm normalized name: Oral Solution
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral solution of vancomycin
Trial: 3449561
Drug: Semi-solid matrix
RxNorm normalized name: Matrix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semi-solid matrix capsules of vancomycin
Trial: 29076376
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate 100 mg and metformin 500 mg
Trial: 24903122
Drug: Decision Aid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decision Aid (DA) for skin cancer treatment options and value clarification activity
Trial: 16816509
Drug: Plasma derived
RxNorm normalized name: c1-inhibitor, plasma derived
DrugBank: Human C1-esterase inhibitor (DB06404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma derived hepatitis B vaccine (pre‐S and S antigens)
Trial: 16816509
Drug: Recombinant hepatitis
RxNorm normalized name: Recombinant hepatitis B human immunoglobulin
DrugBank: Lenvervimab (DB17814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant hepatitis B vaccine (S antigen only)
Trial: 14627860
Drug: 644 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 644 mg/d DT56a
Trial: 14627860
Drug: 344 mg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 344 mg/d DT56a supplemented with calcium
Trial: 9111487
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (SIT) with standardized allergen extracts
Trial: 1587966
Drug: IV omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV omeprazole 40 mg over 2.5 min
Trial: 1587966
Drug: IV omeprazole
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV omeprazole 80 mg over 5 min
Trial: 2941404
Drug: Teicoplanin 200
RxNorm normalized name: Teicoplanin 200 mg powder for solution for injection vial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teicoplanin 200 mg intramuscularly
Trial: 2941404
Drug: Amoxycillin 3
RxNorm normalized name: Amoxycillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxycillin 3 g orally
Trial: 30326952
Drug: Monthly malaria
RxNorm normalized name: Plasmodium malariae
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly malaria prophylaxis (MMP) with dihydroartemisinin-piperaquine and weekly primaquine for 12 weeks
Trial: 30326952
Drug: Focused screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focused screening and treating (FSAT) following current Cambodian national treatment guidelines
Trial: 27685606
Drug: Neutralizing IL‐25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neutralizing IL‐25 antibody
Trial: 22072378
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg Astaxanthin (AXT) per day for 4 weeks
Trial: 7866682
Drug: CATEGO syndromes
RxNorm normalized name: Syndros
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CATEGO syndromes SD and OD (biological features of depression)
Trial: 27495295
Drug: Weight loss
RxNorm normalized name: HERBAL WEIGHT LOSS AID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weight loss intervention (16 weekly group sessions or 5 group sessions and 10 phone calls) (Phase II)
Trial: 10542973
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF DPI) 100 mcg b.i.d.
Trial: 10542973
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF DPI) 200 mcg b.i.d.
Trial: 10542973
Drug: Mometasone furoate
RxNorm normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Mometasone furoate dry powder inhaler (MF DPI) 400 mcg b.i.d.
Trial: 10542973
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) 168 mcg b.i.d.
Trial: 28300506
Drug: SOC +
RxNorm normalized name: Sorafenib
DrugBank: Sorafenib (DB00398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SOC + Cel (Celecoxib 400 mg twice a day for 1 year)
Trial: 28300506
Drug: SOC +
RxNorm normalized name: Sorafenib
DrugBank: Sorafenib (DB00398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SOC + ZA + Cel (Zoledronic acid 4 mg for six 3-weekly cycles, then 4-weekly for 2 years, plus Celecoxib 400 mg twice a day for 1 year)
Trial: 28300506
Drug: SOC (Standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SOC (Standard of care hormone therapy)
Trial: 25455832
Drug: Manual and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual and manipulative therapy (MMT) alone
Trial: 15337407
Drug: 10-day melarsoprol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10-day melarsoprol treatment
Trial: 15337407
Drug: Alternative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatment (10-day melarsoprol)
Trial: 11177478
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied 3 times/week
Trial: 11177478
Drug: Imiquimod 5%
RxNorm normalized name: Imiquimod 5% Topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imiquimod 5% cream applied once per day
Trial: 14753231
Drug: triazolam (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triazolam (0.25 mg)
Trial: 9342777
Drug: capsule chosen
RxNorm normalized name: LANCET,CHOSEN DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: capsule chosen (either placebo or triazolam)
Trial: 7933683
Drug: 201Tl reinjection
RxNorm normalized name: Thallium (201Tl) chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 201Tl reinjection SPECT with sublingual nitroglycerin (NTG)
Trial: 7933683
Drug: 201Tl reinjection
RxNorm normalized name: Thallium (201Tl) chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 201Tl reinjection SPECT without sublingual nitroglycerin (NTG)
Trial: 20943066
Drug: Sublingual immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual immunotherapy with monomeric allergoid (Lais, Lofarma) at three different maintenance doses
Trial: 18548957
Drug: Mandibular dentures
RxNorm normalized name: ALCOHOL,DENATURED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mandibular dentures retained by 1 or 2 implants
Trial: 6857178
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) administration
Trial: 17208410
Drug: VPA syrup
RxNorm normalized name: VPA
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VPA syrup (250mg)
Trial: 17208410
Drug: VPA capsule
RxNorm normalized name: VPA
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: VPA capsule (250mg)
Trial: 17208410
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium sprinkle capsule (250mg)
Trial: 17208410
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium enteric-coated delayed-release tablet (250mg)
Trial: 17208410
Drug: Divalproex sodium
RxNorm normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Divalproex sodium extended-release (divalproex-ER) tablet (250mg)
Trial: 2903874
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (1.5 million units over 1 hour)
Trial: 2903874
Drug: Oral aspirin
RxNorm normalized name: aspirin Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral aspirin (160 mg/day for 1 month)
Trial: 2903874
Drug: Both streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both streptokinase and aspirin
Trial: 2899772
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of streptokinase and aspirin
Trial: 631642
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion at 0.12 microgram/min
Trial: 631642
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion at 0.25 microgram/min
Trial: 631642
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion at 4 microgram/min
Trial: 631642
Drug: Adrenaline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenaline infusion (various doses)
Trial: 28844118
Drug: MDCO-216 (5-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDCO-216 (5-40 mg/kg)
Trial: 23644901
Drug: No CPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No CPAP therapy (Control)
Trial: 19470987
Drug: Optimized antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimized antidepressant therapy followed by a pain self-management program (12 weeks of therapy + 6 sessions of self-management over 12 weeks + 6 months continuation)
Trial: 19470987
Drug: Optimized antidepressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimized antidepressant therapy followed by a pain self-management program
Trial: 15502599
Drug: Fluoxetine 20
RxNorm normalized name: fluoxetine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20 to 60 mg/day
Trial: 27255431
Drug: GL +
RxNorm normalized name: GL-2045
DrugBank: GL-2045 (DB16971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GL + sita (sitagliptin + insulin glargine)
Trial: 27255431
Drug: NOV (premixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NOV (premixed insulin aspart 30)
Trial: 25448109
Drug: Full-dose IPV
RxNorm normalized name: Rho(D) immune globulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Full-dose IPV intramuscularly with needle and syringe
Trial: 25448109
Drug: fIPV intradermally
RxNorm normalized name: Poliovirus, inactivated, fractional-dose (fIPV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fIPV intradermally administered with one of two new injectors
Trial: 25448109
Drug: fIPV administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fIPV administered with BCG needle
Trial: 25448109
Drug: fIPV administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fIPV administered with a conventional needle-free injector